Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SILOthis companySilo Pharma, Inc.	$1.61	-0.68×	0.45×	39.53×	0.45×	443.7%	-1128.9%	-5937.0%	-5863.5%	-67.0%	-61.5%	-163.6%	0×	1.14×	-114.76×	11.36×	0.0%	1	-6	2	C+
CNSPCNS Pharmaceuticals, Inc.	$4.09	-0.15×	0.51×	0×	0.29×	75.0%	0.0%	0.0%	0.0%	-350.5%	-329.5%	-594.1%	0.07×	0.43×	-1,049.68×	1.98×	0.0%	1	-7.36	2	C+
GRIGRI Bio, Inc.	$1.83	-0.06×	0.11×	0×	0.62×	4375.4%	0.0%	0.0%	0.0%	-199.0%	-197.0%	-1502.1%	0.01×	0.68×	0×	3.25×	0.0%	1	-6.79	3	B
JAGXJaguar Health, Inc.	$0.40	-0.04×	-0.13×	0.19×	-0.87×	-26951593.0%	67.2%	-391.9%	-464.2%	309.1%	-178.3%	265.8%	-2.52×	-0.82×	673.25×	0.5×	0.0%	3	-20.02	2	C
SNGXSoligenix, Inc.	$0.34	-0.63×	1.31×	0×	0.05×	251.4%	0.0%	0.0%	0.0%	-209.4%	-200.5%	-147.7%	0.07×	0.65×	0×	2.39×	0.0%	2	-34.78	3	B
Peer median	—	-0.1×	0.31×	0×	0.17×	163.2%	0.0%	0.0%	0.0%	-204.2%	-198.8%	-370.9%	0.04×	0.54×	0×	2.18×	0.0%	2	-13.69	3	—